Small intestinal bacterial overgrowth in inactive Crohn's disease: Influence of thiopurine and biological treatment

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Rodríguez E

Grupos

Abstract

AIM: To investigate the influence of thiopurines and biological drugs on the presence of small intestinal bacterial overgrowth (SIBO) in patients with inactive Crohn's disease (CD). METHODS: This was a prospective study in patients with CD in remission and without corticosteroid treatment, included consecutively from 2004 to 2010. SIBO was investigated using the hydrogen glucose breath test. RESULTS: One hundred and seven patients with CD in remission were included. Almost 58% of patients used maintenance immunosuppressant therapy and 19.6% used biological therapy. The prevalence of SIBO was 16.8%. No association was observed between SIBO and the use of thiopurine Immunosuppressant (12/62 patients), administration of biological drugs (2/21 patients), or with double treatment with an anti-tumor necrosis factor drugs plus thiopurine (1/13 patients). Half of the patients had symptoms that were suggestive of SIBO, though meteorism was the only symptom that was significantly associated with the presence of SIBO on univariate analysis (P < 0.05). Multivariate analysis revealed that the presence of meteorism and a fistulizing pattern were associated with the presence of SIBO (P < 0.05). CONCLUSION: Immunosuppressants and/or biological drugs do not induce SIBO in inactive CD. Fistulizing disease pattern and meteorism are associated with SIBO. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.

Datos de la publicación

ISSN/ISSNe:
1007-9327, 2219-2840

WORLD JOURNAL OF GASTROENTEROLOGY  BAISHIDENG PUBLISHING GROUP INC

Tipo:
Article
Páginas:
13999-14003
PubMed:
25320539
Factor de Impacto:
0,914 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 29

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Crohn's disease; Bacterial overgrowth; Thiopurines; Biologics; Inflammatory bowel disease

Campos de Estudio

Cita

Compartir